Local Institution - 0126

Seoul 8308

1 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Sjögren's Syndrome

Studies at this site

• Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) — Starting soon
• A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome — Running, not enrolling